MASSA, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 391
EU - Europa 224
AS - Asia 160
AF - Africa 45
SA - Sud America 1
Totale 821
Nazione #
US - Stati Uniti d'America 390
IT - Italia 85
SG - Singapore 67
CN - Cina 65
SE - Svezia 56
CI - Costa d'Avorio 32
AT - Austria 25
IN - India 16
GB - Regno Unito 14
BG - Bulgaria 13
SN - Senegal 7
NG - Nigeria 6
DE - Germania 5
PL - Polonia 5
TR - Turchia 5
CH - Svizzera 4
FI - Finlandia 3
HK - Hong Kong 3
LT - Lituania 3
NL - Olanda 3
VN - Vietnam 3
RO - Romania 2
RU - Federazione Russa 2
BE - Belgio 1
BR - Brasile 1
CZ - Repubblica Ceca 1
FR - Francia 1
LK - Sri Lanka 1
MX - Messico 1
UA - Ucraina 1
Totale 821
Città #
Santa Clara 70
Chandler 55
Shanghai 41
Fairfield 37
Abidjan 32
Singapore 30
Vienna 25
Milan 21
New York 18
Boardman 16
Seattle 15
Florence 14
Hyderabad 13
Sofia 13
Woodbridge 13
Wilmington 12
London 10
Lawrence 8
Princeton 8
Ann Arbor 7
Ashburn 7
Cambridge 7
Dakar 7
Pisa 7
San Diego 7
Lagos 6
Istanbul 5
Ogden 5
Quanzhou 5
Cascina 4
Council Bluffs 4
Houston 4
The Dalles 4
Warsaw 4
Zurich 4
Beijing 3
Center 3
Frankfurt am Main 3
Helsinki 3
Hong Kong 3
Los Angeles 3
Medford 3
Santa Croce sull'Arno 3
Castiglione Chiavarese 2
Kent 2
Lucca 2
Norwalk 2
Philadelphia 2
Rome 2
Serra 2
Vicopisano 2
Bremen 1
Brussels 1
Changsha 1
Formigine 1
Fort Worth 1
Fulham 1
Fuzhou 1
Garbagnate Milanese 1
Hangzhou 1
Marseille 1
Mexico City 1
Minneapolis 1
New Delhi 1
North Charleston 1
Olomouc 1
Pietrasanta 1
Redwood City 1
Santa Rita do Itueto 1
Shenzhen 1
Stuttgart 1
Vicenza 1
Wuhan 1
Totale 600
Nome #
Early Tumor Shrinkage and Depth of Response Evaluation in Metastatic Pancreatic Cancer Treated with First Line Chemotherapy: An Observational Retrospective Cohort Study 125
Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel 88
Gemcitabine plus nab-paclitaxel induces PD-L1 mRNA expression in plasma-derived microvesicles in pancreatic cancer 82
Immune checkpoint inhibitors in esophageal cancers: Are we finally finding the right path in the mist? 81
First-line gemcitabine plus nab-paclitaxel for elderly patients with metastatic pancreatic cancer: Crossing the frontier of age? 72
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: A survey of young oncologists 56
Early increase of plasma soluble VEGFR-2 is associated with clinical benefit from second-line treatment of paclitaxel and ramucirumab in advanced gastric cancer 55
Primary Resistance to Immunotherapy-Based Regimens in First Line Hepatocellular Carcinoma: Perspectives on Jumping the Hurdle 50
The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib 45
Equivalent efficacy but different safety profiles of gemcitabine plus nab-paclitaxel and folfirinox in metastatic pancreatic cancer 40
Predictive significance of circulating histones in hepatocellular carcinoma patients treated with sorafenib 34
Dynamic profiling of the immune tumor microenvironment in locally advanced gastric cancer treated with perioperative chemotherapy 32
Mismatch Repair Deficiency in Biliary Tract Cancer: Prognostic Implications and Correlation with Histology 23
Correction to: Sequential Treatment of Sorafenib-Regorafenib Versus Sorafenib-Physician's Choice: A Propensity Score-Matched Analysis 21
Network meta-analysis of adjuvant chemotherapy in biliary tract cancers: Setting the scene for new randomized evidence 18
null 15
Sequential Treatment of Sorafenib–Regorafenib Versus Sorafenib–Physician’s Choice: A Propensity Score-Matched Analysis 9
Concordance of PD-L1 status in primary gastroesophageal adenocarcinoma and matched peritoneal metastases: a single institution study 8
Sequential Treatment of Sorafenib-Regorafenib Versus Sorafenib-Physician's Choice: A Propensity Score-Matched Analysis 3
Totale 857
Categoria #
all - tutte 3.914
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.914


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202025 0 0 0 0 0 0 4 5 4 3 6 3
2020/202153 1 2 2 3 0 19 2 3 8 1 3 9
2021/202281 0 0 0 3 12 27 3 1 3 9 7 16
2022/2023250 18 33 18 11 28 33 2 25 62 0 16 4
2023/2024161 11 15 23 8 17 14 24 2 1 8 13 25
2024/2025262 1 33 20 39 50 95 24 0 0 0 0 0
Totale 857